Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma.
about
Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancerModeling in vivo relative biological effectiveness in particle therapy for clinically relevant endpoints.The influence of breathing motion and a variable relative biological effectiveness in proton therapy of left-sided breast cancer.Radiobiological issues in proton therapy.Charged-particle therapy in cancer: clinical uses and future perspectives.Proton radiobiology and its clinical implications.Empowering Intensity Modulated Proton Therapy Through Physics and Technology: An Overview.The role of image-guided intensity modulated proton therapy in glioma.Impact of respiratory motion on variable relative biological effectiveness in 4D-dose distributions of proton therapy.Linear energy transfer incorporated intensity modulated proton therapy optimization.Differential gene expression in primary fibroblasts induced by proton and cobalt-60 beam irradiation.Rethink radiotherapy - BIGART 2017.New insights in the relative radiobiological effectiveness of proton irradiation.Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β.Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.Relative biological effectiveness in proton beam therapy - Current knowledge and future challenges.Fast robust dose calculation on GPU for high-precision H, He, C and O ion therapy: the FRoG platformProton Relative Biological Effectiveness - Uncertainties and Opportunities
P2860
Q30150151-66CB3325-C879-4FC1-A155-DF8B1C66BDD3Q38604190-835B5440-2115-414E-80F1-6CDD929C11D9Q38615999-6F752666-C91E-4E73-8A4B-E9436EF312D7Q38616009-82B82F0D-D0F1-4E1A-85C8-71C23CAAD1C4Q38746213-CDB3324F-9503-4941-BE91-8E8F248C0506Q44979068-B8D9F53E-15D3-40CA-95AF-F105222D855AQ46126509-AF525078-690B-495C-A62E-1B2B11C98B29Q47566812-E217C6AE-F5C1-4CEA-BCD9-3B213BEF892DQ47796052-44A35A73-BC37-4B8F-A2E1-41C2C5F548F0Q47972069-28535928-86B5-4EEB-B698-1419B44BA0A9Q48054504-6802CB12-F3EF-4D1E-9DE0-9774E02C0473Q48282380-22F1CD34-26B7-4AF5-ADF4-CDCF9917D3ABQ49592283-61D4C5E7-CBBB-4DC2-93C9-4883876F6834Q50054898-D4895DE0-0540-4476-9F84-4304691E1DDAQ50075623-86677795-6F64-43E0-A2A2-9A1A72784445Q55355659-B7DF0AB1-FD94-4164-84E3-986EBC72D331Q57031843-D4BA34E1-FC05-435E-A751-1C75B9C613A8Q58130744-A9A99BBC-5459-45A9-A2CD-E9764101B0B4
P2860
Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Clinical evidence of variable ...... tients treated for ependymoma.
@en
Clinical evidence of variable ...... tients treated for ependymoma.
@nl
type
label
Clinical evidence of variable ...... tients treated for ependymoma.
@en
Clinical evidence of variable ...... tients treated for ependymoma.
@nl
prefLabel
Clinical evidence of variable ...... tients treated for ependymoma.
@en
Clinical evidence of variable ...... tients treated for ependymoma.
@nl
P2093
P2860
P1476
Clinical evidence of variable ...... tients treated for ependymoma.
@en
P2093
Anita Mahajan
David R Grosshans
Dragan Mirkovic
Jillian R Gunther
Pierre Blanchard
P2860
P304
P356
10.1016/J.RADONC.2016.11.001
P577
2016-11-16T00:00:00Z